drugset / Trial / NCT07164326
Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Dexmedetomidine nebulization in sever preeclamptic patients
Timeline
- Start
- 2025-10-15
- Primary completion
- 2026-11-15
- Completion
- 2026-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | — | Other |
Indications
No indication recorded.